Insights

/ 6
Type
Type
Industry
Industry
Pharma Services September 2023
Bluebook

Pharma Services September 2023

Highlights from this edition: Vax Trials was acquired by The Emmes Company, LLC Grant Avenue Capital, LLC announced its acquisition...

Download Now
Diagnostics and Tools September 2023
Bluebook

Diagnostics and Tools September 2023

Highlights from this edition: Gedi Cube was acquired by Renovaro Biosciences Inc. (NasdaqCM:RENB) Repligen Corporation (NasdaqGS:RGEN) announced its ...

Download Now
Pharma Services October 2023
Bluebook

Pharma Services October 2023

Highlights from this edition: Clinical Trial Data Services was acquired by Veramed Limited P95 announced its acquisition of Clinical Research...

Download Now
Diagnostics and Tools October 2023
Bluebook

Diagnostics and Tools October 2023

Highlights from this edition: Olink Holding AB (NasdaqGM:OLK) was acquired by Thermo Fisher Scientific Inc. (NYSE:TMO) iCON Infrastructure LLP ...

Download Now
Pharma Services November 2023
Bluebook

Pharma Services November 2023

Highlights from this edition: PhysIQ was acquired by Prolaio Gauge Capital announced its acquisition of East Coast Institute for Research...

Download Now
Pharma Services January 2019
Bluebook

Pharma Services January 2019

Transactions in the Pharma Services – Development industry totaled ten mergers & acquisitions and one financing during the month of...

Download Now
Diagnostics & Tools January 2019
Bluebook

Diagnostics & Tools January 2019

Transactions in the Diagnostics & Tools industry totaled fourteen mergers & acquisitions and eighteen financings during the month of January...

Download Now
Diagnostics & Tools February 2019
Bluebook

Diagnostics & Tools February 2019

Transactions in the Diagnostics & Tools industry totaled eleven mergers & acquisitions and seventeen financings during the month of February...

Download Now
Pharma Services February 2019
Bluebook

Pharma Services February 2019

Transactions in the Pharma Services industry totaled eleven mergers & acquisitions and three financings during the month of February In...

Download Now
Diagnostics & Tools March 2019
Bluebook

Diagnostics & Tools March 2019

Transactions in the Diagnostics & Tools industry totaled fifteen mergers & acquisitions and twenty-four financings during the month of March...

Download Now
Pharma Services March 2019
Bluebook

Pharma Services March 2019

Transactions in the Pharma Services – Development industry totaled six mergers & acquisitions and three financings during the month of...

Download Now
Diagnostics & Tools April 2019
Bluebook

Diagnostics & Tools April 2019

Transactions in the Diagnostics & Tools industry totaled eleven mergers & acquisitions and twenty-five financings during the month of April...

Download Now
Pharma Services April 2019
Bluebook

Pharma Services April 2019

Transactions in the Pharma Services – Development industry totaled five mergers & acquisitions and two financings during the month of...

Download Now
Diagnostics & Tools May 2019
Bluebook

Diagnostics & Tools May 2019

Transactions in the Diagnostics & Tools industry totaled six mergers & acquisitions and twenty-six financings during the month of May...

Download Now
Pharma Services May 2019
Bluebook

Pharma Services May 2019

Transactions in the Pharma Services – Development industry totaled nine mergers & acquisitions and five financings during the month of...

Download Now
Pharma Services June 2019
Bluebook

Pharma Services June 2019

Medidata Solutions, Inc. was acquired by Dassault Systemes SA for $5.8B ArisGlobal LLC was acquired by Nordic Capital Axio Research,...

Download Now
Diagnostics & Tools June 2019
Bluebook

Diagnostics & Tools June 2019

Blue Earth Diagnostics was acquired by Bracco Imaging for $450M Transplant Genomics was acquired by Eurofins Scientific Singular BIO was...

Download Now
Diagnostics & Tools July 2019
Bluebook

Diagnostics & Tools July 2019

Genomic Health was acquired by Exact Sciences BioTek Instruments was acquired by Agilent Technologies Jungla was acquired by Invitae Corporation...

Download Now
Pharma Services July 2019
Bluebook

Pharma Services July 2019

OmniComm Systems to be acquired by Anju Software HistoGeneX was acquired by Arsenal Capital Partners Caprion Proteomics was acquired by...

Download Now
Diagnostics & Tools August 2019
Bluebook

Diagnostics & Tools August 2019

Toronto Chemical Research acquired by LGC Limited Keystone Biologics acquired by BioIVT Cytena GmbH acquired by Cellink ProMedDx/GLAS acquired by...

Download Now
Pharma Services August 2019
Bluebook

Pharma Services August 2019

THREAD acquired by Water Street Healthcare Partners, JLL Partners Comprehend Systems acquired by Saama Technologies PharmaSeek acquired by ...

Download Now
Diagnostics & Tools September 2019
Bluebook

Diagnostics & Tools September 2019

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also ...

Download Now
Pharma Services September 2019
Bluebook

Pharma Services September 2019

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also ...

Download Now
Pharma Services October 2019
Bluebook

Pharma Services October 2019

eResearchTechnology received an investment from Astorg Partners and Nordic Capital Fund IX Haematologic Technologies was acquired by Edgewater ...

Download Now
Diagnostics & Tools October 2019
Bluebook

Diagnostics & Tools October 2019

Haematologic Technologies was acquired by Edgewater Capital Partners; Crosstree acted as the financial advisor to Haematologic Technologies Certain ...

Download Now
Diagnostics & Tools November 2019
Bluebook

Diagnostics & Tools November 2019

LGC Ltd. was acquired by Astorg Partners TGR Biosciences/Innova Biosciences/Expedeon were acquired by Abcam Animal Research Models Business Unit of...

Download Now
Pharma Services November 2019
Bluebook

Pharma Services November 2019

LGC Ltd. was acquired by Astorg Partners Centex Studies, Clinical Research of Atlanta, and Okanagan Clinical Trials were acquired by...

Download Now
Diagnostics & Tools December 2019
Bluebook

Diagnostics & Tools December 2019

Hitachi’s Diagnostic Imaging Related Business was acquired by Fujifilm HemaCare was acquired by Charles River Laboratories Biological Industries was ...

Download Now
Pharma Services December 2019
Bluebook

Pharma Services December 2019

Catalyst Regulatory Services was acquired by Veristat AKESOgen was acquired by Tempus Labs HealthiVibe was acquired by Corrona Core Diagnostics...

Download Now
Pharma Services January 2020
Bluebook

Pharma Services January 2020

Pharma Services – Development Statistics Collaborative acquired by WIRB-Copernicus Group Cunesoft acquired by Phlexglobal Ashfield Pharmacovigilance ...

Download Now
Diagnostics & Tools January 2020
Bluebook

Diagnostics & Tools January 2020

Blueprint Genetics acquired by Quest Diagnostics Andrew Alliance to be acquired by Waters Corporation Insight Genetics to be acquired by...

Download Now
Diagnostics & Tools March 2020
Bluebook

Diagnostics & Tools March 2020

QIAGEN N.V. to be acquired by Thermo Fisher Scientific Diploid was acquired by Invitae TeraRecon was acquired by SymphonyAI Marker...

Download Now
Pharma Services March 2020
Bluebook

Pharma Services March 2020

Pharma Services  Model Answers was acquired by PAREXEL Richmond Behavioral Associates was acquired by Evolution Research Group (ERG) Genelex was...

Download Now
Diagnostics & Tools March 2020
Bluebook

Diagnostics & Tools March 2020

Partners Group Holding announced it acquisition of Healius Limited Exalenz Biosciences was acquired by Meridian Biosciences Wellbeing Software Group ...

Download Now
Pharma Services March 2020
Bluebook

Pharma Services March 2020

Pharma Services  Human Health Biometrics Division of Clindata was acquired by Synteract Pharmacology Capabilities of Excellerate Biosciences was ...

Download Now
Diagnostics & Tools April 2020
Bluebook

Diagnostics & Tools April 2020

Celsee was acquired by Bio-Rad Laboratories Luminist Labs acquired by DiscernDx MedGenome raised $55MM from Investors

Download Now
Pharma Services April 2020
Bluebook

Pharma Services April 2020

Pharma Services  Biotranex was acquired by Frontage Laboratories MedGenome raised $55MM from Investors Perspectum closed $36MM financing round, ...

Download Now
Diagnostics & Tools May 2020
Bluebook

Diagnostics & Tools May 2020

Stratos Genomics was acquired by Roche Holding AG UrSure was acquired by OraSure Technologies KorvaLabs was acquired by Curative

Download Now
Pharma Services May 2020
Bluebook

Pharma Services May 2020

Pharma Services ActiGraph was acquired by ArchiMed Cytapex Bioinformatics was acquired by Insightful Science AbCellera Biologics Closed a $105mm ...

Download Now
Pharma Services June 2020
Bluebook

Pharma Services June 2020

ArcherDx was acquired by Invitae APDM was acquired by ERT TRSS was acquired by EP Mediate

Download Now
Diagnostics & Tools June 2020
Bluebook

Diagnostics & Tools June 2020

ArcherDx was acquired by Invitae Bluebee Holding BV was acquired by Illumina Mid America Clinical Laboratories was acquired by Quest...

Download Now
Pharma Services July 2020
Bluebook

Pharma Services July 2020

GlobalCare Clinical Trials was acquired by Covance Vium was acquired by Recursion Pharmaceuticals AIT Biosciences was acquired by Nexelis

Download Now
Diagnostics & Tools July 2020
Bluebook

Diagnostics & Tools July 2020

Brava Diagnostics was acquired by mBio Diagnostics Avanti Polar Lipids was acquired by Croda International The Native Antigen Company was...

Download Now
Diagnostics & Tools August 2020
Bluebook

Diagnostics & Tools August 2020

Ancestory.com was acquired by The Blackstone Group Varian Medical Systems was acquired by Siemens Healthineers Coastal Genomics was acquired by...

Download Now
Pharma Services August 2020
Bluebook

Pharma Services August 2020

Clinical Ink was acquired by Harvest Partners Ce3 was acquired by Catalyst Clinical Research Comparative Biosciences was acquired by Genesis...

Download Now
Pharma Services September 2020
Bluebook

Pharma Services September 2020

Array Biostatistics was acquired by CATO SMS ArchiMed acquired a majority stake in North American Science Associates Within3 closed a...

Download Now
Diagnostics & Tools September 2020
Bluebook

Diagnostics & Tools September 2020

GRAIL was acquired by Illumina Canopy Biosciences was acquired by Bruker Advanced Instruments was acquired by Patricia Industries

Download Now
Diagnostics & Tools October 2020
Bluebook

Diagnostics & Tools October 2020

Thrive Earlier Detection was acquired by Exact Sciences Base Genomics was acquired by Exact Sciences BIA Separations was acquired by...

Download Now
Pharma Services October 2020
Bluebook

Pharma Services October 2020

Medsavana closed a $15mm round of funding, led by Cathay Innovation Fund Synteract was acquired by Syneos Health Datavant closed...

Download Now
Diagnostics & Tools November 2020
Bluebook

Diagnostics & Tools November 2020

Talis Biomedical Corporation received a $126mm round of funding Change Healthcare sold assets to HealthStream Congenica closed a $51.2mm round...

Download Now
Pharma Services November 2020
Bluebook

Pharma Services November 2020

IntegReview IRB was acquired by Advarra Shanghai Youlin Pharmaceutical Technology closed a $14.9mm round of funding, led by Cenova Ventures...

Download Now
Pharma Services December 2020
Bluebook

Pharma Services December 2020

Trifecta was acquired by WCG Honeywell has agreed to acquire Sparta Systems for $1.3bb Tempus Labs received a $450mm round...

Download Now
Diagnostics & Tools December 2020
Bluebook

Diagnostics & Tools December 2020

Philips has agreed to acquire BioTelemetry for $2.8bb Verily Life Sciences received a $700mm round of funding Everly Well received...

Download Now
Diagnostics & Tools January 2021
Bluebook

Diagnostics & Tools January 2021

Boston Scientific has agreed to acquire Preventice Solutions for $950mm Thermo Fisher Scientific has agreed to acquire Mesa Biotech for...

Download Now
Pharma Services January 2021
Bluebook

Pharma Services January 2021

Advarra has acquired YourEncore Pfutzner Science & Health Institute was acquired by Diakard Hangzhou Calibra Diagnostics closed a $23mm round...

Download Now
Diagnostics & Tools February 2021
Bluebook

Diagnostics & Tools February 2021

Veracyte has agreed to acquire Decipher Biosciences for $670mm Exact Sciences Corporation has agreed to acquire Ashion Analytics for $140mm...

Download Now
Pharma Services February 2021
Bluebook

Pharma Services February 2021

ICON has agreed to acquire PRA Health Sciences for approximately $12bb, Veristat has acquired SQN Clinical, Altasciences has acquired WCCT Global

Download Now
Diagnostics & Tools March 2021
Bluebook

Diagnostics & Tools March 2021

Roche has agreed to acquire GenMark Diagnostics for $1.9bb Agilent Technologies has agreed to acquire Resolution Bioscience for approximately ...

Download Now
Pharma Services March 2021
Bluebook

Pharma Services March 2021

ICON has agreed to acquire PRA Health Sciences for approximately $12bb, Veristat has acquired SQN Clinical, Altasciences has acquired WCCT Global

Download Now
Diagnostics & Tools April 2021
Bluebook

Diagnostics & Tools April 2021

The Caryle Group has agreed to acquire Unchained Labs for $435mm DiaSorin has agreed to acquire Luminex for $2bb Avantor...

Download Now
Pharma Services April 2021
Bluebook

Pharma Services April 2021

ICON has agreed to acquire PRA Health Sciences for approximately $12bb, Veristat has acquired SQN Clinical, Altasciences has acquired WCCT Global

Download Now
Pharma Services May 2021
Bluebook

Pharma Services May 2021

ICON has agreed to acquire PRA Health Sciences for approximately $12bb, Veristat has acquired SQN Clinical, Altasciences has acquired WCCT Global

Download Now
Diagnostics & Tools May 2021
Bluebook

Diagnostics & Tools May 2021

CellCarta has acquired Reveal Biosciences NeoGenomics Laboratories has agreed to acquire Inivata for $390mm Caris Life Sciences has received $830mm...

Download Now
Pharma Services June 2021
Bluebook

Pharma Services June 2021

Quartesian has been acquired by Summit Partners, 4G Clinical has received $230mm in a round of funding led by Goldman Sachs Asset Management, and ...

Download Now
Diagnostics & Tools June 2021
Bluebook

Diagnostics & Tools June 2021

Insilico has received $255mm in a round of funding led by Warburg Pincus,Veracyte has agreed to acquire HalioDx for $318mm, and Docon has agreed to ...

Download Now
Pharma Services July 2021
Bluebook

Pharma Services July 2021

OmniSeq has been acquired by LabCorp, VeraSci has been acquired by WCG, and Health Decisions has been acquired by Premier Research.

Download Now
Diagnostics & Tools July 2021
Bluebook

Diagnostics & Tools July 2021

PerkinElmer has agreed to acquire BioLegend $5.25bb, Pacific Biosciences of California has agreed to acquire Omniome for approximately $760mm, and ...

Download Now
Diagnostics & Tools August 2021
Bluebook

Diagnostics & Tools August 2021

Thompson Street Capital Partners has agreed to acquire Vector Laboratories for $124mm, Abcam has agreed to acquire BioVision for approximately ...

Download Now
Pharma Services August 2021
Bluebook

Pharma Services August 2021

OmniSeq has been acquired by LabCorp, VeraSci has been acquired by WCG, and Health Decisions has been acquired by Premier Research.

Download Now
Diagnostics & Tools September 2021
Bluebook

Diagnostics & Tools September 2021

Baxter International has agreed to acquire Hillrom for approximately $12.3bb, Pacific Biosciences has raised $300mm in a round of funding, and ...

Download Now
Pharma Services September 2021
Bluebook

Pharma Services September 2021

Inotiv has agreed to acquire Enivgo for approximately $540mm, Elligo Health Research has acquired ClinEdge, Velocity Clinical Research has acquired ...

Download Now
Diagnostics & Tools October 2021
Bluebook

Diagnostics & Tools October 2021

Bio-Rad Laboratories acquired Dropworks for $125mm, Bionano Genomics agreed to acquire BioDiscovery for $100mm, Castle Biosciences agreed to acquire ...

Download Now
Pharma Services October 2021
Bluebook

Pharma Services October 2021

Flourish Research acquired Excel Medical Clinical, TrialsProPharma acquired Pharmica Consulting, Blackstone agreed to acquire Nucleus Network.

Download Now
Pharma Services November 2021
Bluebook

Pharma Services November 2021

Cinven has agreed to acquire BioAgilytix, Labcorp has agreed to acquire Toxikon, Lightbeam Health Solutions has acquired CareSignal

Download Now
Diagnostics & Tools November 2021
Bluebook

Diagnostics & Tools November 2021

Bio-Rad Laboratories acquired Dropworks for $125mm, Bionano Genomics agreed to acquire BioDiscovery for $100mm, Castle Biosciences agreed to acquire ...

Download Now
Diagnostics & Tools December 2021
Bluebook

Diagnostics & Tools December 2021

Thermo Fisher Scientific acquired PeproTech for $1.85bb, LabCorp has agreed to acquire Personal Genome Diagnostics for $575mm, and Quidel has agreed ...

Download Now
Pharma Services December 2021
Bluebook

Pharma Services December 2021

Pharmalex has acquired Pharmasol, Flatiron Health has acquired Protocol First, and Healius has agreed to acquire Agilex Biolabs for $215mm.

Download Now
Diagnostics & Tools January 2022
Bluebook

Diagnostics & Tools January 2022

PreventionGenetics was acquired by Exact Sciences for $190mm, Sema4 has agreed to acquire GeneDx for approximately $620mm, and Freenome received ...

Download Now
Pharma Services January 2022
Bluebook

Pharma Services January 2022

BBK Worldwide was acquired by Publicis Health, Phlexglobal was acquired by PharmaLex, and RealTime Software Solutions has received a strategic ...

Download Now
Pharma Services February 2022
Bluebook

Pharma Services February 2022

Definitive Healthcare has acquired Analytical Wizards for $70mm, Velocity Clinical Research has acquired Trier Health, and CenExel Clinical Research ...

Download Now
Diagnostics & Tools February 2022
Bluebook

Diagnostics & Tools February 2022

Becton, Dickinson and Company has acquired Cytognos, Spatial Genomics has received $56mm in a round of funding led by Fulgent Genetics, and Quaero ...

Download Now
Pharma Services March 2022
Bluebook

Pharma Services March 2022

ConcertAI has raised $150mm in a round of funding led by Sixth Street Partners North American Science Associates has acquired AKRN Scientific ...

Download Now
Diagnostics & Tools March 2022
Bluebook

Diagnostics & Tools March 2022

Grenova has received funding from Peloton Equity BillionToOne has received $125mm in funding in a round led by Adams Street Partners DNAnexus has ...

Download Now
Diagnostics & Tools April 2022
Bluebook

Diagnostics & Tools April 2022

Groupe Bruxelles Lambert (GBL) has agreed to acquire Affidea for approximately $1bb - bioMérieux has agreed to acquire Specific Diagnostics for ...

Download Now
Pharma Services April 2022
Bluebook

Pharma Services April 2022

Clarify Health Solutions has raised $165mm in a round of funding led by SoftBank Vision Fund 2 Biofourmis Singapore has raised $300mm in a round of ...

Download Now
Pharma Services May 2022
Bluebook

Pharma Services May 2022

Novotech has acquired NCGS, CenExel Clinical Research has acquired iResearch Atlanta, Curebase has received $40mm in a round of funding led by ...

Download Now
Diagnostics & Tools May 2022
Bluebook

Diagnostics & Tools May 2022

Ultima Genomics has received $600mm in a round of funding, GTCR has acquired PathGroup, QIAGEN has agreed to acquire BLIRT

Download Now
Pharma Services June 2022
Bluebook

Pharma Services June 2022

Advarra, Inc. was acquired by Blackstone Inc., Fujiebio Europe N.V. announced its acquisition of ADx NeuroSciences NV, Florence Healthcare, Inc. ...

Download Now
Diagnostics and Tools June 2022
Bluebook

Diagnostics and Tools June 2022

NKT Photonics A/S was acquired by Hamamatsu Photonics K.K., EQT Partners AB, PPD, Inc. announced its acquisition of Envirotainer AB, L7 Informatics, ...

Download Now
Pharma Services September 2022
Bluebook

Pharma Services September 2022

iuvo BioScience, LLC was acquired by Ampersand Management LLC, BioIVT has announced its acquisition of XenoTech, LLC, PurpleLab, Inc. closed a $40mm ...

Download Now
Diagnostics and Tools September 2022
Bluebook

Diagnostics and Tools September 2022

MBio Diagnostics, Inc. was acquired by Heska Corporation (NasdaqCM:HSKA), Biosynex SA (ENXTPA:ALBIO) announced its acquisition of Theradiag SA, ...

Download Now
Pharma Services October 2022
Bluebook

Pharma Services October 2022

Cognitive Research Corporation was acquired by River Cities Capital Fund Management AmplifyBio, LLC announced its acquisition of PACT Pharma, Inc. ...

Download Now
Diagnostics and Tools October 2022
Bluebook

Diagnostics and Tools October 2022

The Binding Site Group Ltd. was acquired by Thermo Fisher Scientific Inc. (NYSE:TMO), Sebia SA announced its acquisition of Zeus Scientific, Inc., ...

Download Now
Pharma Services November 2022
Bluebook

Pharma Services November 2022

Egin Research Ltd was acquired by Velocity Clinical Research Inc., Clarest Health announced its acquisition of CSS Health and Integrity Pharmacy, ...

Download Now
Diagnostics and Tools November 2022
Bluebook

Diagnostics and Tools November 2022

Purigen Biosystems, Inc. was acquired by Bionano Genomics, Inc. (NasdaqCM:BNGO), Biocare Medical, LLC announced its acquisition of Empire Genomics, ...

Download Now
Diagnostics and Tools December 2022
Bluebook

Diagnostics and Tools December 2022

ACT Genomics Co., Ltd. was acquired by Prenetics Global Limited (NasdaqGM:PRE), Rezolut, LLC announced its acquisition of CNY Diagnostic Imaging ...

Download Now
Pharma Services December 2022
Bluebook

Pharma Services December 2022

ACT Genomics Co., Ltd. was acquired by Prenetics Global Limited (NasdaqGM:PRE), Everest Clinical Research Services Inc. announced its acquisition of ...

Download Now
Diagnostics and Tools January 2023
Bluebook

Diagnostics and Tools January 2023

Seven Bridges Genomics Inc., PierianDx, Inc., and UgenTec was acquired by Summa Equity AB, Bayer Aktiengesellschaft (XTRA:BAYN) announced its ...

Download Now
Pharma Services January 2023
Bluebook

Pharma Services January 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Pharma Services February 2023
Bluebook

Pharma Services February 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Diagnostics and Tools February 2023
Bluebook

Diagnostics and Tools February 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Pharma Services March 2023
Bluebook

Pharma Services March 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Diagnostics and Tools March 2023
Bluebook

Diagnostics and Tools March 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Pharma Services April 2023
Bluebook

Pharma Services April 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Diagnostics and Tools April 2023
Bluebook

Diagnostics and Tools April 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Pharma Services May 2023
Bluebook

Pharma Services May 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Diagnostics and Tools May 2023
Bluebook

Diagnostics and Tools May 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Diagnostics and Tools June 2023
Bluebook

Diagnostics and Tools June 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Pharma Services June 2023
Bluebook

Pharma Services June 2023

Clinical Trials Mobile Application was acquired by Telemedicine Technologies S.A.S., Bruker Corporation (NasdaqGS:BRKR) announced its acquisition of ...

Download Now
Pharma Services July 2023
Bluebook

Pharma Services July 2023

Highlights from this edition: Genpro Research Inc. was acquired by Catalyst Clinical Research, LLC Alcanza Clinical Research, LLC announced its...

Download Now
Diagnostics and Tools July 2023
Bluebook

Diagnostics and Tools July 2023

Highlights from this edition: Quantigen, LLC was acquired by Versiti, Inc. Novacyt UK Holdings Limited announced its acquisition of Yourgene...

Download Now
Pharma Services August 2023
Bluebook

Pharma Services August 2023

Highlights from this edition: Monroe Biomedical Research was acquired by New Harbor Capital Exact Care Pharmacy, LLC announced its acquisition...

Download Now
Diagnostics and Tools August 2023
Bluebook

Diagnostics and Tools August 2023

Highlights from this edition: QDx Pathology was acquired by LabGenomics Experity, Inc. announced its acquisition of OnePacs, LLC Viome, Inc....

Download Now
Pharma Services January 2024
Bluebook

Pharma Services January 2024

Highlights from this edition: Science 37 Holdings, Inc. was acquired by eMed, LLC, Janvier Labs announced its acquisition of Yecuris, Neocis, In. ...

Download Now
Diagnostics and Tools January 2024
Bluebook

Diagnostics and Tools January 2024

Highlights from this edition: Sofie Biosciences, Inc. (25.8% stake) was acquired by Trilantic Capital Management L.P., Roche Diagnostics Corporation ...

Download Now
Diagnostics and Tools February 2024
Bluebook

Diagnostics and Tools February 2024

Highlights from this edition: Freenome, Inc. closed a $254MM Series A Financing, led by Roche Diagnostics Corporation, Triple Ring Technologies ...

Download Now
Pharma Services February 2024
Bluebook

Pharma Services February 2024

Highlights from this edition: Continuum Clinical was acquired by Spectrum Science a Portfolio Company of Knox Lane, Headlands Research announced its ...

Download Now
Diagnostics and Tools March 2024
Bluebook

Diagnostics and Tools March 2024

Highlights from this edition: Invicro, LLC was acquired by Calyx Services Inc., Telix Pharmaceuticals Limited (ASX:TLX) announced its acquisition of ...

Download Now
Pharma Services March 2024
Bluebook

Pharma Services March 2024

Highlights from this edition: Endpoint Clinical and Patient Access Businesses of Fortrea was acquired by Arsenal Capital Partners, Calyx Services ...

Download Now
Diagnostics and Tools April 2024
Bluebook

Diagnostics and Tools April 2024

Highlights from this edition: Invitae Assets (Genetic Testing) was acquired by Labcorp, Eurofins Scientific SE (ENXTPA:ERF) announced its acquisition ...

Download Now
Pharma Services April 2024
Bluebook

Pharma Services April 2024

Highlights from this edition: Creapharm was acquired by Myonex, Windrose Health Investors announced its acquisition of Subject Well, Xaira ...

Download Now
Pharma Services May 2024
Bluebook

Pharma Services May 2024

Highlights from this edition: Blackstone Inc. (NYSE:BX) announced its acquisition of I'rom Group Co., Ltd. (TSE:2372), Sift Medical Data, Inc. closed ...

Download Now
Diagnostics and Tools May 2024
Bluebook

Diagnostics and Tools May 2024

Highlights from this edition: Invitae was acquired by Labcorp, Quest Diagnostics announced its acquisition of PathAI, Karius, Inc. closed a $100MM ...

Download Now
Pharma Services June 2024
Bluebook

Pharma Services June 2024

Highlights from this edition: Pro-Ficiency Holdings was acquired by Simulations Plus, Inc. (NasdaqGS:SLP), Integral Diagnostics Limited (ASX:IDX) ...

Download Now
Diagnostics and Tools June 2024
Bluebook

Diagnostics and Tools June 2024

Highlights from this edition: Moleculent closed a $26MM Series A Financing, led by Arch Venture Partners, RareCyte closed a $20MM Growth Financing, ...

Download Now
Pharma Services July 2024
Bluebook

Pharma Services July 2024

Highlights from this edition: BridgeView Life Sciences was acquired by Zensar Technologies, Exima Research Network, LLC announced its acquisition of ...

Download Now
Diagnostics and Tools July 2024
Bluebook

Diagnostics and Tools July 2024

Highlights from this edition: Eurobio Scientific was acquired by MBK Partners, Astorg announced its acquisition of Hamilton Thorne, CytoReason closed ...

Download Now
Diagnostics and Tools Blue Book August 2024
Bluebook

Diagnostics and Tools Blue Book August 2024

Highlights from this edition: Exscientia was acquired by Recursion, Getinge announced its acquisition of Paragonix, Openwater closed a $100MM Series ...

Download Now
Pharma Services Blue Book August 2024
Bluebook

Pharma Services Blue Book August 2024

Highlights from this edition: Anju was acquired by Valsoft, Vion Biosciences announced its acquisition of Ansh Labs, Ambrosa Biosciences closed a ...

Download Now
Diagnostics and Tools Blue Book September 2024
Bluebook

Diagnostics and Tools Blue Book September 2024

Highlights from this edition: Integrated Oncology Network was acquired by Cardinal Health, Labcorp Holdings Inc. (NYSE:LH) announced its acquisition ...

Download Now
Pharma Services Blue Book September 2024
Bluebook

Pharma Services Blue Book September 2024

Highlights from this edition: Vectura Group was acquired by Molex Asia Holdings, Better Choice Company Inc. (NYSEAM:BTTR) announced its acquisition ...

Download Now
Industry Leaders Panel Discussion: Patient Access Organizations
Videos

Industry Leaders Panel Discussion: Patient Access Organizations

An in-depth panel discussion on the evolution of clinical trial site organizations into  Patient Access Organizations (PAOs), and their growing ...

Watch Now
Precision and Specialty Medicines’ Impact on the Future of Clinical Trials
Whitepaper

Precision and Specialty Medicines’ Impact on the Future of Clinical Trials

Precision and Specialty Medicine are shaping the future of clinical trials. In this white paper, learn how these changes impact the clinical trial ...

Learn More
Positioning Biobanking Assets for Maximum Value Leveraging the Precision Medicine Opportunity for Biobanks.
Whitepaper

Positioning Biobanking Assets for Maximum Value Leveraging the Precision Medicine Opportunity for Biobanks.

Precision Medicine offers new opportunities for value creation. In this white paper, learn how to build and adapt inorganic growth strategies for ...

Learn More
Inorganic Growth Strategies in Precision Medicine Forging New Paths to Value Creation in the Future of Healthcare.
Whitepaper

Inorganic Growth Strategies in Precision Medicine Forging New Paths to Value Creation in the Future of Healthcare.

Precision Medicine offers new opportunities for value creation. In this white paper, learn how to build and adapt inorganic growth strategies for ...

Learn More
Patient Access Organizations - An Emerging Ecosystem
Whitepaper

Patient Access Organizations - An Emerging Ecosystem

Welcome to the future of clinical trials, where traditional research sites are evolving into sophisticated Patient Access Organizations (PAOs). Our ...

Learn More
Clinical Pharmacology Associates Acquired by SFBC International August 4, 2003
Deal Insights

Clinical Pharmacology Associates Acquired by SFBC International August 4, 2003

Crosstree Capital Partners was the exclusive financial advisor for Clinical Pharmacology Associates.

Learn More
Beacon Bioscience Acquired by ICON July 1, 2004
Deal Insights

Beacon Bioscience Acquired by ICON July 1, 2004

Crosstree Capital Partners served as exclusive financial advisor to Beacon Biosciences.

Learn More
Dynarand acquired by UBC April 21, 2005
Deal Insights

Dynarand acquired by UBC April 21, 2005

Crosstree Capital Partners was the exclusive financial advisor for Dynarand, LLC.

Learn More
Pharmastar acquired by UBC April 21, 2005
Deal Insights

Pharmastar acquired by UBC April 21, 2005

Crosstree Capital Partners served as exclusive financial advisor to PharmaStar, LLC.

Learn More
Primus Corporation Acquired by Trinity Biotech July 21, 2005
Deal Insights

Primus Corporation Acquired by Trinity Biotech July 21, 2005

Crosstree Capital Partners served as exclusive financial advisor to Primus Corporation.

Learn More
Jubilant Organosys Ltd. Acquired Target Research Associates October 5, 2005
Deal Insights

Jubilant Organosys Ltd. Acquired Target Research Associates October 5, 2005

Crosstree Capital Partners served as financial advisor to Jubilant Organosys in the transaction.

Learn More
DataLabs acquired Broadpeak November 7, 2005
Deal Insights

DataLabs acquired Broadpeak November 7, 2005

DataLabs was advised in their acquisition of Broadpeak by Crosstree Capital Partners.

Learn More
InfoPro acquired by Aptuit November 14, 2005
Deal Insights

InfoPro acquired by Aptuit November 14, 2005

Crosstree Capital Partners was the exclusive financial advisor to InfoPro Solutions.

Learn More
Clintrak acquired by Fisher Scientific International Inc. April 11, 2006
Deal Insights

Clintrak acquired by Fisher Scientific International Inc. April 11, 2006

Crosstree Capital Partners was the exclusive financial advisor for Clintrak Pharmaceutical Services.

Learn More
Bridge Laboratories Raised $35M in Series B Preferred Shares from Aisling Capital and Lehman Brothers June 14, 2006
Deal Insights

Bridge Laboratories Raised $35M in Series B Preferred Shares from Aisling Capital and Lehman Brothers June 14, 2006

Crosstree Capital Partners served as exclusive financial advisor to Bridge in the transaction.

Learn More
WorldCare Clinical Acquired by ProScan Imaging June 6, 2006
Deal Insights

WorldCare Clinical Acquired by ProScan Imaging June 6, 2006

Crosstree Capital Partners was the exclusive financial advisor for WorldCare Clinical, LLC.

Learn More
BioCor acquired by UBC November 6, 2006
Deal Insights

BioCor acquired by UBC November 6, 2006

Crosstree Capital served as exclusive financial advisor to BioCor.

Learn More
DataLabs acquired by ClinPhone October 27, 2006
Deal Insights

DataLabs acquired by ClinPhone October 27, 2006

Crosstree Capital served as exclusive financial advisor to DataLabs.

Learn More
Gentiae Raised $16M in Series B Preferred Shares from Bay City Capital and CIBC January 3, 2007
Deal Insights

Gentiae Raised $16M in Series B Preferred Shares from Bay City Capital and CIBC January 3, 2007

Crosstree Capital Partners was the exclusive financial advisor for Gentiae Clinical Research.

Learn More
Martec acquired by Nostrum December 20, 2006
Deal Insights

Martec acquired by Nostrum December 20, 2006

Crosstree served as exclusive financial advisor to Martec USA.

Learn More
Bridge Laboratories Acquired the Preclinical Testing Division of Gene Logic December 20, 2006
Deal Insights

Bridge Laboratories Acquired the Preclinical Testing Division of Gene Logic December 20, 2006

Crosstree Capital Partners served as exclusive financial advisor to Bridge.

Learn More
Medifacts International Acquired by Global Research Services March 23, 2007
Deal Insights

Medifacts International Acquired by Global Research Services March 23, 2007

Crosstree Capital Partners was the exclusive financial advisor for Medifacts International.

Learn More
CRI Worldwide acquired by SV Life Sciences October 3, 2007
Deal Insights

CRI Worldwide acquired by SV Life Sciences October 3, 2007

Crosstree Capital Partners served as exclusive financial advisor for CRI Worldwide, Inc.

Learn More
Radiant Research acquired by ICICI Venture June 8, 2007
Deal Insights

Radiant Research acquired by ICICI Venture June 8, 2007

Crosstree Capital Partners served as financial advisor to Radiant Research.

Learn More
Pacific Data Designs Acquired by DW Healthcare Partners November 6, 2008
Deal Insights

Pacific Data Designs Acquired by DW Healthcare Partners November 6, 2008

Crosstree Capital Partners served as exclusive financial advisor for Pacific Data Designs.

Learn More
Plethico Acquired Natrol December 28, 2007
Deal Insights

Plethico Acquired Natrol December 28, 2007

Financial advisor to Plethico.

Learn More
Micronics raised $6M in Series B Preferred Shares October 16, 2008
Deal Insights

Micronics raised $6M in Series B Preferred Shares October 16, 2008

Crosstree Capital Partners acted as exclusive financial advisor to Micronics in the transaction.

Learn More
Healthcare Discoveries Acquired by ICON February 11, 2008
Deal Insights

Healthcare Discoveries Acquired by ICON February 11, 2008

Crosstree represented Catalyst Pharma Group / Healthcare Discoveries as the exclusive sell-side banker.

Learn More
Phoenix Data Systems Acquired by Bioclinica (formerly Bio-Imaging Technologies) April 28, 2008
Deal Insights

Phoenix Data Systems Acquired by Bioclinica (formerly Bio-Imaging Technologies) April 28, 2008

Crosstree Capital Partners served as exclusive financial advisor for Phoenix Data Systems, Inc.

Learn More
PathNet acquired by LabCorp September 28, 2008
Deal Insights

PathNet acquired by LabCorp September 28, 2008

Crosstree Capital Partners served as exclusive financial advisor to PathNet.

Learn More
Pharmaceutical Profiles Acquired by Quotient Bioscience December 15, 2008
Deal Insights

Pharmaceutical Profiles Acquired by Quotient Bioscience December 15, 2008

Crosstree Capital Partners acted as the exclusive financial advisor for Pharmaceutical Profiles Limited.

Learn More
American Diagnostica acquired by SCKISUI March 23, 2009
Deal Insights

American Diagnostica acquired by SCKISUI March 23, 2009

Crosstree Capital Partners was the exclusive financial advisor to American Diagnostica, Inc. in the transaction.

Learn More
Endpoint received a strategic investment from Chiltern March 31, 2010
Deal Insights

Endpoint received a strategic investment from Chiltern March 31, 2010

Crosstree Capital Partners served as the exclusive financial advisor for Endpoint.

Learn More
Enthalpy Bioanalytical Testing Division Acquired by LabCorp June 11, 2010
Deal Insights

Enthalpy Bioanalytical Testing Division Acquired by LabCorp June 11, 2010

Crosstree Capital Partners served as exclusive financial advisor to Enthalpy Analytical.

Learn More
MediSync Acquired by Vyteris April 18, 2011
Deal Insights

MediSync Acquired by Vyteris April 18, 2011

Financial advisor to MediSync.

Learn More
Synthetech acquired by Grace September 13, 2010
Deal Insights

Synthetech acquired by Grace September 13, 2010

Financial advisor to Synthetech.

Learn More
FirstSource Laboratory Solutions Acquired by LabCorp September 14, 2010
Deal Insights

FirstSource Laboratory Solutions Acquired by LabCorp September 14, 2010

Crosstree Capital Partners served as exclusive financial advisor to FirstSource Laboratory Solutions.

Learn More
DMD Acquired by Aptilon September 18, 2009
Deal Insights

DMD Acquired by Aptilon September 18, 2009

Financial advisor to DMD.

Learn More
CentralCoast Pathology laboratory business acquired by Sonic Healthcare February 7, 2011
Deal Insights

CentralCoast Pathology laboratory business acquired by Sonic Healthcare February 7, 2011

Crosstree Capital Partners acted as exclusive financial advisor to CCPC in the transaction.

Learn More
Arrowhead acquired by MedCo July 28, 2011
Deal Insights

Arrowhead acquired by MedCo July 28, 2011

Crosstree Capital Partners acted as exclusive financial advisor to Arrowhead in the transaction.

Learn More
MDCI Acquired by Aptiv Solutions and SV Life Sciences August 22, 2011
Deal Insights

MDCI Acquired by Aptiv Solutions and SV Life Sciences August 22, 2011

Crosstree Capital Partners served as exclusive financial advisor to MDCI.

Learn More
Mediatech Acquired by Corning December 1, 2011
Deal Insights

Mediatech Acquired by Corning December 1, 2011

Overview Corning Incorporated (NYSE: GLW) announced that it has completed the acquisition of Mediatech, Inc., a Virginia-based corporation, including ...

Learn More
Biomain Acquired by Heraeus March 1, 2012
Deal Insights

Biomain Acquired by Heraeus March 1, 2012

Financial advisor to Biomain.

Learn More
invivodata Acquired by ERT and Genstar Capital, LLC July 9, 2012
Deal Insights

invivodata Acquired by ERT and Genstar Capital, LLC July 9, 2012

Crosstree Capital initiated and closed this transaction as exclusive financial advisor to invivodata.

Learn More
Paragon Biomedical acquired by Clinipace WorldWide September 25, 2012
Deal Insights

Paragon Biomedical acquired by Clinipace WorldWide September 25, 2012

Crosstree Capital Partners served as Paragon's investment banker and financial advisor.

Learn More
Predictive Biosciences anatomic pathology business acquired by Miraca Life Sciences November 19, 2012
Deal Insights

Predictive Biosciences anatomic pathology business acquired by Miraca Life Sciences November 19, 2012

Crosstree Capital Partners served as exclusive financial advisor to Predictive Biosciences.

Learn More
Pacific Physicians Laboratory, Inc. Acquired by LabCorp December 11, 2012
Deal Insights

Pacific Physicians Laboratory, Inc. Acquired by LabCorp December 11, 2012

Overview On December 11, 2012, Crosstree Capital Partners announced the sale of Pacific Physicians Laboratory, Inc. In Lynnwood, Washington to ...

Learn More
Cytolab Pathology Services Acquired by LabCorp December 11, 2012
Deal Insights

Cytolab Pathology Services Acquired by LabCorp December 11, 2012

Crosstree Capital Partners served as exclusive financial advisor to Cytolab Pathology Services.

Learn More
IMP Logistics Acquired by PRA and Genstar Capital, LLC March 4, 2013
Deal Insights

IMP Logistics Acquired by PRA and Genstar Capital, LLC March 4, 2013

Crosstree Capital Partners served as exclusive financial advisor to ClinStar.

Learn More
IMP Logistics Acquired by PRA and Genstar Capital, LLC March 4, 2013
Deal Insights

IMP Logistics Acquired by PRA and Genstar Capital, LLC March 4, 2013

Overview PRA, a leading clinical research, announced it has acquired privately held ClinStar, LLC, a clinical research organization managing Phase ...

Learn More
BioAgilytix Labs Acquired by Riverside Partners June 4, 2013
Deal Insights

BioAgilytix Labs Acquired by Riverside Partners June 4, 2013

Crosstree Capital Partners served as exclusive financial advisor to BioAgilytix Labs.

Learn More
Critical Path Service Acquired by Knoell June 13, 2013
Deal Insights

Critical Path Service Acquired by Knoell June 13, 2013

Crosstree Capital Partners served as exclusive financial advisor to CPS.

Learn More
Converge acquired by Quest Diagnostics October 7, 2013
Deal Insights

Converge acquired by Quest Diagnostics October 7, 2013

Crosstree Capital Partners served as exclusive financial advisor to Water Street and ConVerge.

Learn More
Ancora acquired by Corden Pharma November 12, 2013
Deal Insights

Ancora acquired by Corden Pharma November 12, 2013

Financial advisor to Ancora.

Learn More
Accelrys Acquired QUMAS December 9, 2013
Deal Insights

Accelrys Acquired QUMAS December 9, 2013

Financial advisor to Accelrys.

Learn More
TTM Acquired by Indegene January 2, 2014
Deal Insights

TTM Acquired by Indegene January 2, 2014

Financial advisor to TTM.

Learn More
Gentris acquired by Cancer Genetics July 21, 2014
Deal Insights

Gentris acquired by Cancer Genetics July 21, 2014

Crosstree Capital Partners served as exclusive financial advisor to Gentris.

Learn More
Fountain Medical Development (FMD) merged with K&L consulting services September 1, 2014
Deal Insights

Fountain Medical Development (FMD) merged with K&L consulting services September 1, 2014

Crosstree served as the exclusive financial advisor to Fountain Medical Development.

Learn More
Durbin acquired Pharmaceutical Trade Services, Inc. (PTSI) December 1, 2014
Deal Insights

Durbin acquired Pharmaceutical Trade Services, Inc. (PTSI) December 1, 2014

Financial advisor to Durbin.

Learn More
ePharmaSolutions Received a Strategic Investment from Arsenal Capital Partners and WIRB-Copernicus Group September 24, 2014
Deal Insights

ePharmaSolutions Received a Strategic Investment from Arsenal Capital Partners and WIRB-Copernicus Group September 24, 2014

Crosstree Capital Partners represented ePS in its transaction with WCG.

Learn More
Focus Pharmaceuticals Ltd. Acquired by AMCo October 1, 2014
Deal Insights

Focus Pharmaceuticals Ltd. Acquired by AMCo October 1, 2014

Financial and strategic advisor to Focus Pharmaceuticals.

Learn More
PHT acquired by ERT and Genstar Capital May 11, 2015
Deal Insights

PHT acquired by ERT and Genstar Capital May 11, 2015

Crosstree Capital Partners served as PHT's exclusive financial advisor.

Learn More
Cliniqa acquired by Bio-Techne July 9, 2015
Deal Insights

Cliniqa acquired by Bio-Techne July 9, 2015

Crosstree Capital Partners served as exclusive financial advisor to Cliniqa Corporation.

Learn More
ILS Genomics Acquired by LabCorp July 31, 2015
Deal Insights

ILS Genomics Acquired by LabCorp July 31, 2015

Crosstree Capital Partners served as exclusive financial advisor to Integrated Laboratory Systems, Inc., parent of ILS Genomics.

Learn More
Baylor College of Medicine (BDC) assets acquired by Cell Medica June 17, 2016
Deal Insights

Baylor College of Medicine (BDC) assets acquired by Cell Medica June 17, 2016

Financial advisor to Baylor College of Medicine.

Learn More
Mo Bio acquired by Qiagen January 11, 2016
Deal Insights

Mo Bio acquired by Qiagen January 11, 2016

Crosstree Capital Partners acted as exclusive financial advisor to MO BIO.

Learn More
Ducere Pharma acquired by Dr. Reddy’s May 25, 2016
Deal Insights

Ducere Pharma acquired by Dr. Reddy’s May 25, 2016

Financial advisor to Ducere Pharma.

Learn More
Clinical Pharmacology of Miami acquired by Evolution Research Group
Deal Insights

Clinical Pharmacology of Miami acquired by Evolution Research Group

Crosstree Capital Partners served as exclusive financial advisor to CPMI.

Learn More
GQ Life Sciences acquired by Aptean October 3, 2016
Deal Insights

GQ Life Sciences acquired by Aptean October 3, 2016

Financial advisor to GQ Life Sciences.

Learn More
ProPhase acquired by WCG and Arsenal Capital Partners May 9, 2017
Deal Insights

ProPhase acquired by WCG and Arsenal Capital Partners May 9, 2017

Overview WIRB-Copernicus Group (WCGTM) announced its acquisition of MedAvante and ProPhase. WCG is the leading provider of solutions that improve the ...

Learn More
Tulip Group acquired by PerkinElmer January 9, 2017
Deal Insights

Tulip Group acquired by PerkinElmer January 9, 2017

Financial advisor to Tulip Group.

Learn More
IDT acquired the Oligo Manufacturing Business of GeneWorks February 8, 2017
Deal Insights

IDT acquired the Oligo Manufacturing Business of GeneWorks February 8, 2017

Crosstree Capital Partners initiated this transaction on behalf of IDT.

Learn More
MedAvante acquired by Arsenal Capital Partners and WCG May 9, 2017
Deal Insights

MedAvante acquired by Arsenal Capital Partners and WCG May 9, 2017

Crosstree Capital Partners acted as exclusive financial advisor to MedAvante.

Learn More
Chemical Computing Group Received a Majority Investment from Altaris June 8, 2017
Deal Insights

Chemical Computing Group Received a Majority Investment from Altaris June 8, 2017

Financial advisor to Chemical Computing Group.

Learn More
Access Regional Laboratory Business acquired by LabCorp June, 2017
Deal Insights

Access Regional Laboratory Business acquired by LabCorp June, 2017

Crosstree Capital Partners acted as exclusive financial advisor to Access.

Learn More
OmniSeq Received a Strategic Investment from LabCorp August 21, 2017
Deal Insights

OmniSeq Received a Strategic Investment from LabCorp August 21, 2017

Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq Inc.

Learn More
Trevigen acquired by Bio-Techne September 5, 2017
Deal Insights

Trevigen acquired by Bio-Techne September 5, 2017

Crosstree Capital Partners acted as exclusive financial advisor to Trevigen.

Learn More
Research Point Global acquired by WuXi AppTec October 17, 2017
Deal Insights

Research Point Global acquired by WuXi AppTec October 17, 2017

Crosstree Capital Partners acted as exclusive financial advisor to ResearchPoint Global (RPG).

Learn More
mProve Health acquired by Bracket October 24, 2017
Deal Insights

mProve Health acquired by Bracket October 24, 2017

Crosstree Capital Partners served as exclusive financial advisor to mProve.

Learn More
Xenometrics acquired by CitoxLab October 31, 2017
Deal Insights

Xenometrics acquired by CitoxLab October 31, 2017

Crosstree Capital Partners served as exclusive financial advisor to Xenometrics.

Learn More
Citoxlab acquired Solvo Biotechnology March 12, 2018
Deal Insights

Citoxlab acquired Solvo Biotechnology March 12, 2018

Crosstree Capital Partners acted as exclusive financial advisor to Citoxlab.

Learn More
MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018
Deal Insights

MedLabs Diagnostics Recapitalized by Caymus Equity and PNC Mezzanine Capital April 3, 2018

Crosstree Capital Partners acted as exclusive financial advisor to MedLabs Diagnostics.

Learn More
OmniSeq Received a Strategic Investment from HITACHI April 12, 2018
Deal Insights

OmniSeq Received a Strategic Investment from HITACHI April 12, 2018

Crosstree Capital Partners acted as exclusive financial advisor to OmniSeq.

Learn More
mPulse Mobile Acquired Message Beam June 2018
Deal Insights

mPulse Mobile Acquired Message Beam June 2018

Crosstree Capital Partners was the exclusive financial advisor for mPulse.

Learn More
Santus Laboratories (owned by HealthEdge Partners) was purchased by DermaRite (owned by Tailwind Capital Group) August 2018
Deal Insights

Santus Laboratories (owned by HealthEdge Partners) was purchased by DermaRite (owned by Tailwind Capital Group) August 2018

Overview Santus Laboratories (owned by HealthEdge Partners) manufactures and sells dermatology products to the institutional market, including ...

Learn More
CareMetx (owned by The Vistria Group) acquired VirMedica (owned by Petra Capital Partners) September 2018
Deal Insights

CareMetx (owned by The Vistria Group) acquired VirMedica (owned by Petra Capital Partners) September 2018

Overview CareMetx, a technology-enabled hub services and provider for pharmaceutical and biotechnology manufacturers, announced its acquisition of ...

Learn More
PhenoPath has been acquired by Quest Diagnostics September 2018
Deal Insights

PhenoPath has been acquired by Quest Diagnostics September 2018

Overview Quest Diagnostics announced the acquisition of PhenoPath, a national provider of specialized anatomic pathology and related services. ...

Learn More
CSM (a portfolio company of Great Point Partners) has been acquired by Clinigen September 2018
Deal Insights

CSM (a portfolio company of Great Point Partners) has been acquired by Clinigen September 2018

Overview Clinigen Group announced the acquisition of Clinical Supplies Management (“CSM”), a specialist provider of packaging, labeling, warehousing ...

Learn More
Transposagen Biopharmaceuticals, Inc. has been acquired by Lonza
Deal Insights

Transposagen Biopharmaceuticals, Inc. has been acquired by Lonza

Overview Transposagen Biopharmaceuticals, Inc. (“Transposagen”) is a leader in gene editing and integration technologies and services with ...

Learn More
Santus Laboratories (owned by HealthEdge Partners) sold Cough/Cold asset to Reliable1 – October 2018
Deal Insights

Santus Laboratories (owned by HealthEdge Partners) sold Cough/Cold asset to Reliable1 – October 2018

Overview Santus Laboratories (owned by HealthEdge Partners) manufactures and sells dermatology products to the institutional market, including ...

Learn More
PMI Preclinical was acquired by Covance, a subsidiary of LabCorp October 2018
Deal Insights

PMI Preclinical was acquired by Covance, a subsidiary of LabCorp October 2018

Overview Covance, the drug and medical device development subsidiary of LabCorp, acquired PMI Preclinical on October 29, 2018. PMI Preclinical is a ...

Learn More
Biorasi Received a Majority Investment from Riordan, Lewis & Haden Equity Partners November 16, 2018
Deal Insights

Biorasi Received a Majority Investment from Riordan, Lewis & Haden Equity Partners November 16, 2018

Overview Biorasi, LLC announced the completion of a majority investment by Riordan, Lewis & Haden Equity Partners (“RLH”) on November 16, 2018. ...

Learn More
GSK Sold Assets to Crown Laboratories
Deal Insights

GSK Sold Assets to Crown Laboratories

Overview GlaxoSmithKline PLC (GSK) is a global pharmaceutical development, manufacturing, and marketing company. GSK sold five branded assets to ...

Learn More
Velos acquired by WCG, a portfolio company of Arsenal Capital Partners
Deal Insights

Velos acquired by WCG, a portfolio company of Arsenal Capital Partners

Overview WIRB-Copernicus Group (WCG), the leading provider of tech-enabled solutions that improve the quality and efficiency of clinical research, ...

Learn More
MolecularMD has been acquired by ICON Plc.
Deal Insights

MolecularMD has been acquired by ICON Plc.

Overview ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced ...

Learn More
DataCeutics has been acquired by Navitas Life Sciences, a TAKE Solutions Company
Deal Insights

DataCeutics has been acquired by Navitas Life Sciences, a TAKE Solutions Company

Overview Navitas Life Sciences, a subsidiary of TAKE Solutions, announced its acquisition of DataCeutics, a provider of statistical data management ...

Learn More
Genstar Capital acquires Advarra from Linden Partners
Deal Insights

Genstar Capital acquires Advarra from Linden Partners

Overview On June 6, 2019, Genstar Capital announced that it signed a definitive agreement to acquire Advarra from Linden Capital Partners. Advarra, ...

Learn More
Anju Software acquires OmniComm Systems
Deal Insights

Anju Software acquires OmniComm Systems

Overview On July 16, 2019, OmniComm Systems (OTCQX: OMCM) announced that it entered into a merger agreement with Anju Software. OmniComm is a ...

Learn More
HistoGeneX combines with Caprion Biosciences via strategic investment from Arsenal Capital Partners
Deal Insights

HistoGeneX combines with Caprion Biosciences via strategic investment from Arsenal Capital Partners

Overview On July 31, 2019, HistoGeneX and Caprion Biosciences announced they have agreed to combine their respective businesses. This combination ...

Learn More
Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses
Deal Insights

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

Overview On September 4, 2019, OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and ...

Learn More
Perrigo Advances Consumer Strategy with Acquisition of Prevacid®24HR from GSK
Deal Insights

Perrigo Advances Consumer Strategy with Acquisition of Prevacid®24HR from GSK

Overview On September 4, 2019, Perrigo acquired branded rights to Prevacid® from GlaxoSmithKline. Under the terms of the agreement, Perrigo will have ...

Learn More
Chonometriq Received an Investment from Full In Partners October 1, 2019
Deal Insights

Chonometriq Received an Investment from Full In Partners October 1, 2019

Overview Chronometriq, founded in 2012, is a leader in digital healthcare management through its suite of products enabling full-cycle appointment ...

Learn More
Haematologic Technologies, Inc. was acquired by Edgewater Capital Partners
Deal Insights

Haematologic Technologies, Inc. was acquired by Edgewater Capital Partners

Overview On October 11, 2019, Edgewater Capital Partners announced they have entered into an agreement to acquire Haematologic Technologies ...

Learn More
WIRB-Copernicus Group (“WCG”) recapitalizes, led by Leonard Green & Partners, L.P.
Deal Insights

WIRB-Copernicus Group (“WCG”) recapitalizes, led by Leonard Green & Partners, L.P.

Overview On November 14, 2019, Leonard Green & Partners, L.P. (“LGP”), in partnership with Arsenal Capital Partners (“Arsenal”) and Novo Holdings ...

Learn More
GSK is selling assets to Foundation Consumer Healthcare
Deal Insights

GSK is selling assets to Foundation Consumer Healthcare

Overview Foundation Consumer Healthcare owned by Kelso Private Equity and Juggernaut Capital, has entered into an agreement to acquire seven branded ...

Learn More
Array Biostatistics was acquired by CATO SMS
Deal Insights

Array Biostatistics was acquired by CATO SMS

Overview CATO SMS has acquired Wilmington, NC-based Array Biostatistics to expand its offering of specialized clinical research solutions. ...

Learn More
IntegReview was acquired by Advarra
Deal Insights

IntegReview was acquired by Advarra

Overview Advarra has acquired Austin-based IntegReview and will integrate its early-phase-focused, specialized IRB solutions into a center of ...

Learn More
Trifecta Clinical was acquired by WCG
Deal Insights

Trifecta Clinical was acquired by WCG

Overview WCG has acquired Los Angeles-based Trifecta Clinical to bolster its remote study startup and compliance support offerings. Significance WCG ...

Learn More
dMed Merged with Clinipace
Deal Insights

dMed Merged with Clinipace

China-based dMed has acquired global CRO Clinipace to provide turnkey, end-to-end development support to clients in any market in the world.

Learn More
Pyxant Labs Bolsters Capabilities in Acquisition of Covance by Labcorp’s SLC Bioanalytical Site
Deal Insights

Pyxant Labs Bolsters Capabilities in Acquisition of Covance by Labcorp’s SLC Bioanalytical Site

Innovative bioanalytical CRO Pyxant Labs acquired assets from Covance by Labcorp to strengthen Pyxant’s business with enhanced capabilities in large ...

Learn More
Quartesian Acquired by Summit Partners to Form New Global Outsourced Medtech Provider
Deal Insights

Quartesian Acquired by Summit Partners to Form New Global Outsourced Medtech Provider

Global independent biometrics company, Quartesian, acquired by Summit Partners to form key pillar of newly established global outsourced medtech ...

Learn More
Clinical Trials of Texas Recapitalized by NMS Capital to Form new Flourish Research Clinical Research Site Platform
Deal Insights

Clinical Trials of Texas Recapitalized by NMS Capital to Form new Flourish Research Clinical Research Site Platform

Clinical Trials of Texas has been recapitalized by NMS Capital to form the new Flourish Research clinical research site platform, to become a ...

Learn More
ZebraSci Acquired by BD to Enhance Combination Product Testing Capabilities
Deal Insights

ZebraSci Acquired by BD to Enhance Combination Product Testing Capabilities

Leading global medical technology manufacturer BD has acquired device development, manufacturing, and testing company ZebraSci to enhance drug-device ...

Learn More
Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise
Deal Insights

Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise

Pharmica Consulting was acquired by ProPharma Group to provide end-to-end clinical trial execution solutions to pharma, biotech, and medical device ...

Learn More
Flourish Research Acquires Excel Medical Clinical Trials to Expand Site Network and Therapeutic Expertise
Deal Insights

Flourish Research Acquires Excel Medical Clinical Trials to Expand Site Network and Therapeutic Expertise

Excel’s site location, therapeutic areas of focus, and expertise made them the ideal addition to Flourish Research’s growing platform, which will ...

Learn More
UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults
Deal Insights

UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults

UpStream Care’s unique model offers support to practices of any size looking to participate in value-based care models.

Learn More
pharmasol Acquired by PharmaLex to Offer Turnkey End-to-End Pharmacovigilance Solutions
Deal Insights

pharmasol Acquired by PharmaLex to Offer Turnkey End-to-End Pharmacovigilance Solutions

pharmasol’s pharmacovigilance solutions provide automated data management, warehousing, and reporting, making their technology the perfect complement ...

Learn More
Protocol First Joins Flatiron Health® to Help Bridge the Gap Between Real-World Care and Clinical Research
Deal Insights

Protocol First Joins Flatiron Health® to Help Bridge the Gap Between Real-World Care and Clinical Research

Protocol First’s leading-edge technology and focus on complex oncological studies made them the perfect strategic fit for Flatiron, the leader in ...

Learn More
PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing
Deal Insights

PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing

PreventionGeneticsis the perfect complement to Exact Sciences’ advanced cancer diagnostics portfolio and supports its entrance into hereditary cancer ...

Learn More
BBK Worldwide Acquired by Publicis Health to Expand Clinical Trial Expertise with Proprietary Technology and Patient-Centric Solutions
Deal Insights

BBK Worldwide Acquired by Publicis Health to Expand Clinical Trial Expertise with Proprietary Technology and Patient-Centric Solutions

By bringing together BBK's proprietary technology and methodologies and Langland's award-winning creative capabilities under one roof, Publicis ...

Learn More
RealTime Software Solutions Receives Strategic Investment from LLR Partners to Accelerate Growth and Product Innovation
Deal Insights

RealTime Software Solutions Receives Strategic Investment from LLR Partners to Accelerate Growth and Product Innovation

RealTime's company’s leadership position in the clinical research technology market made it the perfect investment opportunity for LLR Partners.

Learn More
BCT Recapitalized by Martis Capital Via Its Newly Formed Clinical Research Site Platform, Alcanza Clinical Research
Deal Insights

BCT Recapitalized by Martis Capital Via Its Newly Formed Clinical Research Site Platform, Alcanza Clinical Research

Boston Clinical Trials has been recapitalized by Martis Capital via its newly formed clinical research site platform, Alcanza Clinical Research.

Learn More
Ascent and PharmaLex Merge to Expand Clinical Development Services in Asia
Deal Insights

Ascent and PharmaLex Merge to Expand Clinical Development Services in Asia

Ascent's expertise and pan-Asian infrastructure made it the perfect complement to PharmaLex’s broad CRO services portfolio and existing US and EU ...

Learn More
CCRC Recapitalized by Martis Capital Via Its Newly Formed Clinical Research Site Platform, Alcanza Clinical Research
Deal Insights

CCRC Recapitalized by Martis Capital Via Its Newly Formed Clinical Research Site Platform, Alcanza Clinical Research

Coastal Carolina Research Center has been recapitalized by Martis Capital via its newly formed clinical research site platform, Alcanza Clinical ...

Learn More
Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives
Deal Insights

Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives

Growth recapitalization will enable Grenova to accelerate its sales and marketing efforts, launch additional products, and build out its presence ...

Learn More
Lexitas Acquired by NovaQuest to Support Continued Growth and Capability Expansion
Deal Insights

Lexitas Acquired by NovaQuest to Support Continued Growth and Capability Expansion

Lexitas Pharma Services has been acquired by NovaQuest Private Equity to support continued growth and capability expansion.

Learn More
H.I.G. Capital Acquires Majority Stake in Navitas Life Sciences to Accelerate CRO Growth
Deal Insights

H.I.G. Capital Acquires Majority Stake in Navitas Life Sciences to Accelerate CRO Growth

Lexitas Pharma Services has been acquired by NovaQuest Private Equity to support continued growth and capability expansion.

Learn More
Sabai Global Acquired by Thompson Street Capital Partners to Accelerate IBC and IRB Growth
Deal Insights

Sabai Global Acquired by Thompson Street Capital Partners to Accelerate IBC and IRB Growth

Sabai's specialized services made the Company the ideal target for a strategic growth investment from Thompson Street Capital Partners.

Learn More
LongueVue Capital Partners Acquires Majority Stake in Summit Clinical Research to Accelerate SMO/IRO Growth
Deal Insights

LongueVue Capital Partners Acquires Majority Stake in Summit Clinical Research to Accelerate SMO/IRO Growth

LongueVue Capital Partners has acquired a majority stake in Summit Clinical Research to accelerate SMO/IRO growth.

Learn More
RMC Pharmaceutical Solutions Acquired by Syner-G Biopharma Group, a Portfolio Company of Riverside Partners, to Expand Regulatory Compliance Solutions
Deal Insights

RMC Pharmaceutical Solutions Acquired by Syner-G Biopharma Group, a Portfolio Company of Riverside Partners, to Expand Regulatory Compliance Solutions

The company’s service offerings were the ideal strategic complement to enhance Syner-G’s existing suite of comprehensive CMC solutions.

Learn More
Clairvest Acquires Boca Biolistics to Accelerate Growth of Infectious Disease and Oncological Biobanking Capabilities
Deal Insights

Clairvest Acquires Boca Biolistics to Accelerate Growth of Infectious Disease and Oncological Biobanking Capabilities

Boca’s high growth profile and differentiated positioning within the biobanking industry made it the ideal acquisition for Clairvest’s ongoing ...

Learn More
OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials
Deal Insights

OpenClinica Completes Growth Recapitalization with Thompson Street Capital Partners to Accelerate Enablement of Clinical Trials

The company’s service offerings were the ideal strategic complement to enhance Syner-G’s existing suite of comprehensive CMC solutions.

Learn More
anteris Acquired by Kymanox, a Portfolio Company of Westview Capital Partners, to Expand Injectable Combination Product Development Capabilities Globally
Deal Insights

anteris Acquired by Kymanox, a Portfolio Company of Westview Capital Partners, to Expand Injectable Combination Product Development Capabilities Globally

Transaction helps both companies realize their shared goals of geographic expansion, while also bolstering service capabilities.

Learn More
ClinChoice Acquires CROMSOURCE to Expand CRO Capabilities Globally
Deal Insights

ClinChoice Acquires CROMSOURCE to Expand CRO Capabilities Globally

ClinChoice has acquired CROMSOURCE to expand their CRO capabilities globally.

Learn More
Clinical Site Services and Patient Advertising Guru Acquired by American Clinical Research Services to Add Tech-Enabled Patient Recruitment Capabilities
Deal Insights

Clinical Site Services and Patient Advertising Guru Acquired by American Clinical Research Services to Add Tech-Enabled Patient Recruitment Capabilities

Clinical Site Services and Patient Advertising Guru were acquired by American Clinical Research Services to add tech-enabled patient recruitment ...

Learn More
Benchmark Research Acquired by IQVIA, combined with Avacare to Expand Vaccine and Clinical Trial Site Capabilities
Deal Insights

Benchmark Research Acquired by IQVIA, combined with Avacare to Expand Vaccine and Clinical Trial Site Capabilities

ClinChoice has acquired CROMSOURCE to expand their CRO capabilities globally.

Learn More
Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America
Deal Insights

Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America

Access Medical Labs has allied with Grupo Diagnostico Aries to expand their diagnostic lab capabilities into North America.

Learn More
Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering
Deal Insights

Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering

Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering

Learn More
Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities
Deal Insights

Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network and Clinical Trial Execution Capabilities

Accel Research Sites Network Acquired by Alcanza Clinical Research, a portfolio company of Martis Capital, to Expand its Clinical Trial Site Network ...

Learn More
Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings
Deal Insights

Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings

Catalyst Clinical Research, a portfolio company of QHP Capital, acquired Genpro Research to expand global footprint and deepen service offerings

Learn More
QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally
Deal Insights

QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally

QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally

Learn More
SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU
Deal Insights

SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand Into the EU

SSI Strategy, a Portfolio Company of Amulet Capital Partners, Acquired NDA Group AB to Bolster Regulatory Affairs Consulting Capabilities and Expand ...

Learn More
Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform
Deal Insights

Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform

Monroe Biomedical Research Acquired by New Harbor Capital in a First Step to Build-out a Clinical Research Site Platform

Learn More
Grant Avenue Capital Recapitalizes CREO
Deal Insights

Grant Avenue Capital Recapitalizes CREO

Overview Grant Avenue Capital has recapitalized CREO Inc. Significance The life sciences consulting industry is witnessing a dynamic shift as it ...

Learn More
VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities
Deal Insights

VaxTRIALS Acquired by Emmes, a portfolio company of New Mountain Capital, to Expand Vaccine and Clinical Trial Site Capabilities

Overview VaxTRIALS has been acquired by Emmes, a portfolio company of New Mountain Capital, to add a new Latin America base and vaccine research ...

Learn More
Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities
Deal Insights

Versiti Acquired Pearl Pathways to Expand Clinical Trial Services Capabilities

Overview Versiti has acquired Pearl Pathways to strengthen their existing IRB foothold and ability to offer broader regulatory support for clinical ...

Learn More
Romark Laboratories Amount Raised Undisclosed
Deal Insights

Romark Laboratories Amount Raised Undisclosed

Romark Laboratories Amount Raised Undisclosed

Learn More
Digital Healthcare Raised $3,000,000 Preferred Stock through a Placement Agent
Deal Insights

Digital Healthcare Raised $3,000,000 Preferred Stock through a Placement Agent

Digital Healthcare Raised $3,000,000 Preferred Stock through a Placement Agent

Learn More
Scandius Biomedical amount raised undisclosed preferred Equity Placement Agent
Deal Insights

Scandius Biomedical amount raised undisclosed preferred Equity Placement Agent

Scandius Biomedical amount raised undisclosed preferred Equity Placement Agent

Learn More
ProstaLund Acquired by Farstorp
Deal Insights

ProstaLund Acquired by Farstorp

ProstaLund Acquired by Farstorp

Learn More
Chemo assets acquired by Ducere Pharma
Deal Insights

Chemo assets acquired by Ducere Pharma

Chemo assets acquired by Ducere Pharma

Learn More
HCS acquired by Girling
Deal Insights

HCS acquired by Girling

HCS acquired by Girling

Learn More
Semorex acquired by MYOS corporation
Deal Insights

Semorex acquired by MYOS corporation

Semorex acquired by MYOS corporation

Learn More
Senova Systems Acquired by Parker
Deal Insights

Senova Systems Acquired by Parker

Senova Systems Acquired by Parker

Learn More
Medsphere Raised $12,000,000 of Senior Debt
Deal Insights

Medsphere Raised $12,000,000 of Senior Debt

Medsphere Raised $12,000,000 of Senior Debt

Learn More
Viactiv acquired by ADARE and TPG
Deal Insights

Viactiv acquired by ADARE and TPG

Viactiv acquired by ADARE and TPG

Learn More
SunLink Sold Assets to CVS Health
Deal Insights

SunLink Sold Assets to CVS Health

SunLink Sold Assets to CVS Health

Learn More
PBI Financial Advisory
Deal Insights

PBI Financial Advisory

PBI Financial Advisory

Learn More
Imedex Acquired by AmerisourceBergen May 10, 2004
Deal Insights

Imedex Acquired by AmerisourceBergen May 10, 2004

Imedex Acquired by AmerisourceBergen May 10, 2004

Learn More
Ixion Biotechnology Inc. Financial advisory
Deal Insights

Ixion Biotechnology Inc. Financial advisory

Ixion Biotechnology Inc. Financial advisory

Learn More
Atherotech Financial Advisory
Deal Insights

Atherotech Financial Advisory

Atherotech Financial Advisory

Learn More
Candescent Healing Acquired by Candescent Partners
Deal Insights

Candescent Healing Acquired by Candescent Partners

Candescent Healing Acquired by Candescent Partners

Learn More
CMDX Financial Advisory
Deal Insights

CMDX Financial Advisory

CMDX Financial Advisory

Learn More
Aptilon acquired by Indegene November 9, 2012
Deal Insights

Aptilon acquired by Indegene November 9, 2012

Aptilon acquired by Indegene November 9, 2012

Learn More
SigmaCare acquired by Homecare CRM March 10, 2015
Deal Insights

SigmaCare acquired by Homecare CRM March 10, 2015

SigmaCare acquired by Homecare CRM March 10, 2015

Learn More
DrugDev Acquired by QuintilesIMS
Deal Insights

DrugDev Acquired by QuintilesIMS

DrugDev Acquired by QuintilesIMS

Learn More
Pyxant Labs Receives Majority Investment from ArchiMed
Deal Insights

Pyxant Labs Receives Majority Investment from ArchiMed

Pyxant Labs Receives Majority Investment from ArchiMed

Learn More
Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities
Deal Insights

Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities

Alpha IRB Acquired by Sabai Global, a Portfolio Company of Thompson Street Capital, to Expand IRB Capabilities

Learn More
A&J Home Care, Inc. Acquired by HCS
Deal Insights

A&J Home Care, Inc. Acquired by HCS

A&J Home Care, Inc. Acquired by HCS

Learn More
Biosafe Raised $6,500,000 Subordinated Debt Through a Placement Agent
Deal Insights

Biosafe Raised $6,500,000 Subordinated Debt Through a Placement Agent

Biosafe Raised $6,500,000 Subordinated Debt Through a Placement Agent

Learn More
GSK sold assets to Lil’ Drug Store
Deal Insights

GSK sold assets to Lil’ Drug Store

GSK sold assets to Lil’ Drug Store

Learn More
GSK Sold Assets to COMBE
Deal Insights

GSK Sold Assets to COMBE

GSK Sold Assets to COMBE

Learn More
Intrinsic Clinical Systems and Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise
Deal Insights

Intrinsic Clinical Systems and Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise

Intrinsic Clinical Systems and Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise

Learn More
NaviNet Amount Raised Undisclosed, Senior Debt by a Placement Agent
Deal Insights

NaviNet Amount Raised Undisclosed, Senior Debt by a Placement Agent

NaviNet Amount Raised Undisclosed, Senior Debt by a Placement Agent

Learn More
Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering
Deal Insights

Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room Manufacturing Capabilities and Expand Overall Offering

Modular Devices, a Portfolio Company of O2 Investment Partners, Partners with Flow Clean Rooms and Supply to Bolster Existing Clean Room ...

Learn More
Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally
Deal Insights

Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally

Yecuris Corporation Acquired by Janvier Group to Expand Preclinical Service Offering Internationally

Learn More
Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities
Deal Insights

Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities

Continuum Clinical, a BC Worldwide company, Acquired by Spectrum Science, a Portfolio Company of Knox Lane, to Bolster Patient Engagement Capabilities

Learn More
physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research
Deal Insights

physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research

physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research

Learn More
Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions
Deal Insights

Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions

Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions

Learn More
Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US
Deal Insights

Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US

Myonex Acquired SaveWay Compounding Pharmacy to Expand and Bolster its Clinical Trial Services Across the US

Learn More
Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe
Deal Insights

Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of Foothold in Europe

Myonex Acquired Creapharm's Clinical & Commercial Packaging and Bioservices Business Units to Expand Clinical Trial Supply Services and Gain of ...

Learn More
BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering
Deal Insights

BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering

BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering

Learn More
Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network
Deal Insights

Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network

Pinnacle Clinical Research Acquires Kerwin Medical Center to Bolster Clinical Trial Site Network

Learn More
Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network
Deal Insights

Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network

Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network

Learn More
Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities
Deal Insights

Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities

Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities

Learn More
Surfing the Wave: The Patient-Data Puzzle
Articles

Surfing the Wave: The Patient-Data Puzzle

As technology continues to rapidly evolve, opportunities for pharma also increase when it comes to patient data. The existence of information is not ...

Learn More
Crosstree Helps ArchiMed Create Early Drug Development Platform Through Three-way Acquisition
Case Study

Crosstree Helps ArchiMed Create Early Drug Development Platform Through Three-way Acquisition

Recognizing the emerging opportunity of Precision Medicine, ArchiMed engaged Crosstree to help develop and execute its growth strategy in the early ...

Learn More
Innovations in Pharmaceutical Development™
Market Map

Innovations in Pharmaceutical Development™

Introducing Innovations in Pharmaceutical Development™ In this first-of-its-kind book, Crosstree profiles over 50 of the most innovative companies ...

Learn More
Innovation’s Role in Life Sciences with Rick Riegel
Videos

Innovation’s Role in Life Sciences with Rick Riegel

Rick Riegel, Panelist for Crosstree's Innovations in Pharmaceutical Development, discusses the role of innovation in the Life Sciences industry.

Learn More
Global Connectivity and Pharma Development Innovation with Steve Gens
Videos

Global Connectivity and Pharma Development Innovation with Steve Gens

Steve Gens, profiled in Crosstree's Innovations in Pharmaceutical Development, discusses how the trend toward more global connectivity of regulatory ...

Learn More
How Innovations across Pharma Development Delivered the COVID-19 Vaccine with Rick Cimino
Videos

How Innovations across Pharma Development Delivered the COVID-19 Vaccine with Rick Cimino

Rick Cimino, Panelist for Crosstree's Innovations in Pharmaceutical Development, discusses how innovation across the entire Pharma Development ...

Learn More
COVID-19 Impact on Pharma Development Innovation with Steve Sullivan
Videos

COVID-19 Impact on Pharma Development Innovation with Steve Sullivan

Steve Sullivan, Panelist for Crosstree's Innovations in Pharmaceutical Development, discusses how COVID-19 has accelerated innovation in the Pharma ...

Learn More
PharmaVOICE: February 2021
Articles

PharmaVOICE: February 2021

Fueled by the strong financial performance of Pharma Services, Diagnostics and Tools, and Digital Health companies and accelerated by the COVID-19 ...

Learn More
Future of Clinical Trials
Videos

Future of Clinical Trials

This video provides insights to how the future of clinical trials has been impacted by COVID-19.

Learn More
The Prism Doctrine
Market Map

The Prism Doctrine

Tomorrow’s ecosystem must allow for more specialized, complex treatments and patient journeys, which will be tailored to each therapy in the case of ...

Learn More
Precision Medicine Driving M&A
Articles

Precision Medicine Driving M&A

Increasingly complex clinical trials are putting pressure on CROs to expand their service offerings in what has been a historically monolithic space ...

Learn More
Load More

Gain Insight Into The Health
Sciences Industries

Sign up to receive the the latest reports, research, BlueBooks, and more from the Crosstree team.

Subscribe